Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs

Journal of Microencapsulation

Volumn 27, Issue 8, 2010, Pages 682-692

  Boudier, Ariane ^a   Kirilov, Plamen ^a   Franceschi Messant, Sophie ^a   Belkhelfa, Haouaria ^b   Hadioui, Laila ^b   Roques, Christine ^b   Perez, Emile ^a   Rico Lattes, Isabelle ^a  

^a Université Paul Sabatier   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cell internalization; Gelled oil vehicle; Hydrophobic reservoir; Nanoparticle

Indexed keywords

DRUG CARRIER; NANOPARTICLE; POLYETHYLENEIMINE; SOYBEAN OIL;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG FORMULATION; DRUG SCREENING; DRUG STABILITY; EMULSION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROPHOBICITY; INTERNALIZATION; PARTICLE SIZE; RESERVOIR; ROOM TEMPERATURE; SCREENING TEST; SPECTROFLUOROMETRY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; ELECTROCHEMISTRY; FLUORESCENT DYES; GELS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDICATORS AND REAGENTS; KERATINOCYTES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OXAZINES; PARTICLE SIZE; POLYETHYLENEIMINE; SOYBEAN OIL; SPECTROMETRY, FLUORESCENCE; TETRAZOLIUM SALTS; WATER;

EID: 78049465568     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.506582     Document Type: Article

References (38)

1. Abdallah DJ, Weiss RG. Organogels and low molecular mass organic gelators. Adv Mater, 2000;12 (17):1237-47.
2. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev, 2009;61 (6):428-37.
3. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethyleniminemediated DNA transfection and the proton sponge hypothesis. J Gene Med, 2005;7 (5):657-63.
4. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev, 2007;59 (6):478-90.
5. Attama AA, Müller-Goymann CC. Effect of beewax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloid Surf A, 2008;315:189-95.
6. Attama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm, 2008;355:307-13.
7. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther, 1996;3:1074-80.
8. Brioschi A, Zenga F, Zara GP, Gasco MR, Ducati A, Mauro A. Solid lipid nanoparticles: Could they help to improve the efficacy of pharmacologic treatments for brain tumors?. Neurol Res, 2007;29:324-30.
9. Bunjes H, Siekmann B, 2007. Manufacture, characterization and application of solid lipid nanoparticles as drug delivery system. In: Deleers M, Pathak Y, Thassu D, editors. Nanoparticulate Drug Delivery Systems. New York: Informa Healthcare. pp 213-68.
10. Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm, 2002;238:241-5.
11. Chattopadhyay P, Shekunov BY, Yim D, Cipolla D, Boyd B, Farr S. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev, 2007;6:444-53.
12. Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther, 1997;4 (10):1100-6.
13. George M, Weiss RG. Molecular organogels. Soft matter comprised of lowmolecular- mass organic gelators and organic liquids. Acc Chem Res, 2006;39:489-97.
14. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol, 1995;13:996-1003.
15. Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev, 2009;60 (15):1638-49.
16. Huang X, Weiss R. Molecular organogels of the sodium salt of (R)-12- hydroxystearic acid and their templated syntheses of inorganic oxides. Tetrahedron, 2007;63:7375-81.
17. Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN®). J Microenviron, 2001;18:149-58.
18. Jeong SY, Kwon IC, Chung H. 2000. Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier. PCT Int. Appl, WO 2000006120.
19. Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorom-etry and Raman spectroscopy. Pharm Res, 2005;22:1887-95.
20. Joshi MD, Mü ller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm, 2009;71 (2):161-72.
21. Kirilov P, Franceschi-Messant S, Perez E, Rico-Lattes I, Bordat P. 2009a. WO Patent PCT/EP2007/060126.
22. Kirilov P, Gauffre F, Franceschi-Messant S, Perez E, Rico-Lattes I. Rheological characterization of a new type of colloidal dispersion based on nanoparticles of gelled oil. J Phys Chem B, 2009b;113:11101-8.
23. Kirilov P, Lukyanova L, Franceschi-Messant S, Perier V, Perez E, Rico- Lattes I. A new type of colloidal dispersions based on nanoparticles of gelled oil. Colloids Surf A: Physicochem Eng Asp, 2008;328:1-7.
24. Kumar R, Katare Prakash O. Lecithin organogels as a potential phospholipid- structured system for topical drug delivery: A review. AAPS PharmSciTech, 2005;6:E298-E310.
25. Lasic DD. Doxorubicin in sterically stabilized liposomes. Nature, 1996;380:561-2.
26. Li JL, Wang RY, Liu XY, Pan HH. Nanoengineering of a biocompatible organogel by thermal processing. J Phys Chem B, 2009;113(15):5011-5.
27. Lim SJ, Lee MK, Kim CK. Altered chemical and biological activities of alltrans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release, 2004;100:53-61.
28. Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, Zhang Q, He Q, Zhang Z. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm, 2008;356:333-44.
29. Lu L, Weiss RG. Cholestanyl substituted quaternary ammonium salts as gelators of organic liquids. Langmuir, 1995;11:3630-2.
30. Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2001;47:165-96.
31. Mukkamala R, Weiss RG. Physical gelation of organic fluids by anthraquinone - steroid-based molecules. Structural features influencing the properties of gels. Langmuir, 1996;12:1474-82.
32. Mü ller RH, 1991. Colloidal carriers for controlled drug delivery and targeting - modification, characterization and in vivo distribution. Boca Raton: CRC Press.
33. Mü ller RH, Olbrich C. 2000. Drug-delivery vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates. PCT Int. Appl. WO 2000067800.
34. Mü ller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev, 2007;59:522-30.
35. Murdan S, Andrysek T, Son D. Novel gels and their dispersions - oral drug delivery systems for ciclosporin. Int J Pharm, 2005;300:113-24.
36. Murdan S, vanden Bergh B, Gregoriadis G, Florence AT. Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci, 1999;88:615-9.
37. Pardeike J, Hommoss A, Mü ller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 2009;366:170-84.
38. Pisal S, Shelke V, Mahadik K, Kadam S. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS PharmSciTech, 2004;5:E63.